Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AERS Overhaul Will Be Overseen By FDA’s New Bioinformatics Board

Executive Summary

FDA's initiative to develop an advanced Adverse Event Reporting System that has the ability to analyze data and assist medical reviewers in their efforts to spot safety signals will be overseen by a new Bioinformatics Board

You may also be interested in...



FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says

FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts

FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says

FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts

Gottlieb’s New Year’s Wish List: Risk Management Plans Out, Science In

The growing use of risk management plans to mitigate risk in the post-marketing setting presents "potential harm to patients and the practice of medicine," FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb said during a speech on drug safety at the Manhattan Institute in New York Nov. 13

Related Content

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel